Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC-Reference-Cited by-同舟云学术

Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC

Published:2020-11-24 Issue:1 Volume:10 Page:3-14
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med.

Author:

Tian Yaru¹²,Zhai Xiaoyang²,Yan Weiwei¹²,Zhu Hui²^ORCID,Yu Jinming²^ORCID

Affiliation:

1. Department of Radiation Oncology Shandong Cancer Hospital and InstituteShandong University Jinan China

2. Department of Radiation Oncology Shandong Cancer Hospital and InstituteShandong First Medical University and Shandong Academy of Medical Science Jinan China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3590

Reference96 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Institute NC.Seer cancer statistics review.https://seer.cancer.gov/archive/csr/1975_2014/1975–2014

3. Society AC.Cancer facts & figures 2014.Atlanta ga:American Cancer Society;2014.

4. The biology and management of non-small cell lung cancer

5. Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a signature of histone modifiers in kidney renal clear cell carcinoma;Aging;2024-06-17

2. Inhibiting immune escape in lung adenocarcinoma: the role of SPARC in suppressing CD276 function;Biotechnology & Biotechnological Equipment;2024-04-02

3. Qingfei mixture modulates the immune responses in lung cancer through modulating mTOR signaling and gut microbiota-derived short-chain fatty acids;Heliyon;2024-04

4. Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway;Chinese Medicine;2024-03-25

5. Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy;Frontiers in Oncology;2024-03-20